ROBB GARY CHARLES (Chief Business Officer) received a stock award from CORCEPT THERAPEUTICS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/4/2026ACC: 0001193125-26-382457
Officer· Chief Business Officer
Since Mar 2026
+237.00
Net shares
Net buyer
$10.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
328.00 acquired · 91.00 disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+164.00
Price / share
$113.38
Trade value
$18.59K
% of position
1.2%
9/1/2026
13.43K→13.59K
Common Stock
Direct
Shares
+164.00
Price / share
—
Trade value
—
% of position
1.2%
9/1/2026
13.59K→13.75K
Common Stock
Direct
Shares
−91.00
Price / share
$113.38
Trade value
$10.32K
% of position
0.7%
9/2/2026
13.75K→13.66K
Total
Net shares
+237.00
Net value
$8.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/1/2026 | A · Award | +164.00 | $113.38 | $18.59K | 1.2% | 13.43K | 13.59K |
| Common Stock Direct | 9/1/2026 | A · Award | +164.00 | — | — | 1.2% | 13.59K | 13.75K |
| Common Stock Direct | 9/2/2026 | F · Tax Withholding | −91.00 | $113.38 | $10.32K | 0.7% | 13.75K | 13.66K |
| Total | +237.00 | $8.28K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned39.72K
Common Stock
IndirectShares owned15.57K
Common Stock
IndirectShares owned15.57K
Total
70.86K indirect70.86K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 39.72K | Indirect |
| Common Stock | 15.57K | Indirect |
| Common Stock | 15.57K | Indirect |
| Total | 70.86K | 70.86K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported